First U.S. Patient Treated in DISRUPT PAD III Study of Lithoplasty Technology
News | Peripheral Arterial Disease (PAD) | April 12, 2017

April 12, 2017 — PinnacleHealth CardioVascular Institute last week enrolled the first patient in the United States...

Corindus Announces First Robotic-Assisted PCI Procedures Performed in Asia Using CorPath GRX System
News | Robotic Systems | April 12, 2017

April 12, 2017 — Corindus Vascular Robotics Inc. announced that the first...

PinnacleHealth Initiates Clinical Study of TriGuard Embolic Protection Device
News | Embolic Protection Devices | April 11, 2017

April 11, 2017 — Through a new clinical trial, patients at Harrisburg, Pa.-based PinnacleHealth have access to an...

Cardiovascular Systems Inc., CSI, ECLIPSE clinical trial, Diamondback 360 Coronary Orbital Atherectomy System, first subject enrolled
News | Atherectomy Devices | April 04, 2017

April 4, 2017 — Cardiovascular Systems Inc., in partnership with the Cardiovascular Research Foundation (CRF),...

EBBINGHAUS study, evolocumab, repatha, statin therapy, cognitive issues, ACC.17 study
News | Pharmaceuticals | April 03, 2017

April 3, 2017 — There is no evidence that adding a new...

STEMI, cardiac arrest, cardiogenic shock, ACC.17 study, Minneapolis Heart Institute Foundation, MHIF
News | Cath Lab | April 03, 2017

April 3, 2017 — The influence of cardiac arrest and cardiogenic shock on outcomes of patients with...

Henry Ford Hospital, Detroit Cardiogenic Shock Initiative, Impella pump, ACC.17 clinical study
News | Ventricular Assist Devices (VAD) | April 03, 2017

April 3, 2017 — Hospitals can dramatically increase heart attack survival rates in patients suffering cardiogenic...

RenalGuard Therapy, ACC.17, meta-analysis, contrast-induced acute kidney injury, CI-AKI
News | Cath Lab | April 03, 2017

April 3, 2017 — A new meta-analysis further supports the ability of RenalGuard Therapy to significantly reduce the...

Videos | ACC | April 03, 2017

DAIC Editor Dave Fornell takes a tour of some of the interesting new technologies from the vendor booths on the expo...

tryton side branch stent, dedicated coronary side branch stent

The FDA approval of the Tryton Side Branch Stent was the biggest technology news from March. It is deployed in the side branch artery using a standard single wire balloon-expandable stent delivery system. A conventional drug eluting stent is then placed in the main vessel.

Feature | April 03, 2017 | Dave Fornell

April 3, 2017 — Here is the list of the top 25 most popular pieces of content on the Diagnostic and Interventional...

Tryton Medical, Side Branch Stent, first U.S. commercial case, New York-Presbyterian Hospital, Columbia University Medical Center
News | Stents Bifurcation | March 31, 2017

March 31, 2017 — Tryton Medical Inc. recently announced that the first U.S. commercial case using the Tryton Side...

Merit Medical, FDA Class I recall, Prelude Short Sheath Introducer
News | Vascular Access | March 31, 2017

March 31, 2017 — The U.S. Food and Drug Administration (FDA) announced it has initiated a Class I recall of the...

Videos | Stents Bioresorbable | March 30, 2017

Stephen Ellis, M.D., professor of medicine and director of interventional cardiology at Cleveland Clinic, discusses...

atricure atriclip, LAA occlusion, acc17

The AtriCure Atriclip surgical LAA occlusion device. It loops over the LAA on the outside of the heart and clips it off from the rest of the heart to prevent the formation of clots.

Feature | Left Atrial Appendage (LAA) Occluders | March 29, 2017

March 29, 2017 — For patients with...

synthetic HDL-C injection, cholesterol, arterial plaque, heart attack patients, CARAT trial, ACC.17, clinical study
News | Pharmaceuticals | March 29, 2017

March 29, 2017 — Injection of a novel form of synthetic high-density lipoprotein cholesterol (HDL-C), or good...

Overlay Init